Hikal share news, announcements and annual reports
NSE: HIKALBSE: 524735Pharmaceuticals & BiotechnologySmall Cap
Hikal Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1995 on BSE, Feb 2001 on NSE
Last close ₹211.58up ₹7.18 (3.51%)BSE ₹210.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹204.40.
30 Oct: open ₹205.88, high ₹223.70, low ₹204.72
52-week range of traded prices to 30 Oct 2026
₹146.25Low, 30 Mar 2026₹261.00High, 4 Dec 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,609 Cr1,090th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.28%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −2.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹76 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 3.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 40,73,4669.3% delivered
Hikal board meetings
106 filed, newest first. Page 2 of 3.
Apr 2018
Jan 2018
Oct 2017
Aug 2017
May 2017
Jan 2017
Oct 2016
Aug 2016
Apr 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
7 May · Board meeting
Board of Directors in their meeting held on May 5, 2015, has inter alia discussed & approved subject to necessary approvals, raising of funds upto an amount of Rs. 125 crores, by issuing equity shares through qualified institutions placement and / or issue of warrants / equity shares / such other permissible securities on such terms and conditions as may be decided by the Board of Directors and / or Committee of the Board, in accordance with the provisions of Chapter VIII of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 and other applicable laws, subject to approval of the members of the Company.
Apr 2015
Jan 2015
21 Jan · Board meeting
To consider and to take on record the unaudited Financial Result for the quarter end December 31, 2013.
Dec 2014
Oct 2014
28 Oct · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended September 30, 2014.
Jul 2014
30 Jul · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended June 30, 2014.
Jun 2014
Apr 2014
25 Apr · Board meeting
To consider and to take on record the Audited Financial Results and declaration/ recommendation of dividend for the year ended March 31, 2014.
Jan 2014
29 Jan · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended December 31, 2013.
Oct 2013
18 Oct · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended September 30, 2013.
Jul 2013
30 Jul · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended June 30, 2013.
May 2013
16 May · Board meeting
At the board meeting held on May 16, 2013: (1) Mr. Jai Hiremath, Chairman & Managing Director, has been re-appointed for a period of 5 years commencing July 1, 2013 and (2) Mr. Sameer Hiremath, President & Joint Managing Director, has been re-appointed for a period of 5 years commencing July 01, 2013. These appointments are subject to the approval of shareholders in the ensuing Annual General Meeting.7 May · Board meeting
To consider and to take on record the Audited Financial Results for the year ended March 31, 2013.
Jan 2013
29 Jan · Board meeting
To Consider and to take on record the Unaudited Financial Results for the quarter ended December 31, 2012.
Oct 2012
29 Oct · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended September 30, 2012.
Jul 2012
31 Jul · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended June 30, 2012.
May 2012
3 May · Board meeting
To consider and to take on record the Audited Financial Results for the year ended March 31, 2012. The Board will also consider the declaration of Dividend.
Jan 2012
31 Jan · Board meeting
To Consider and to take on record the Unaudited Financial Results for the quarter ended December 31, 2011.
Nov 2011
10 Nov · Board meeting
Board of Directors of the Company at their meeting held on November 10, 2011, considered and approved the Scheme of Arrangement between Hikal Limited ('Hikal' or 'the Company') and Acoris Research Limited ('Acoris') and their respective shareholders and creditors ('Scheme'). The salient features of the Scheme are as under : (1) The Appointed Date of the Scheme is April 1, 2012; (2) Demerger of Research Business Undertaking of Acoris into the company; (3) Since the entire share capital of Acoris is held by the Company, no consideration shall be payable / dischargeable for vesting of the Research Business Undertaking. The Scheme is subject to consent, approval of requisite majority of shareholders and creditors of the Company, Acoris, sanction of the High Court of Judicature at Bombay and all other regulatory approvals as may be necessary for the implementation of the Scheme.2 Nov · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended September 30, 2011.
Jul 2011
19 Jul · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended June 30, 2011.
May 2011
3 May · Board meeting
To consider and to take on record the Audited Financial Results and declaration / recommendation of dividend for the year ended March 31, 2011.
Jan 2011
28 Jan · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended December 31, 2010.
Nov 2010
2 Nov · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended September 30, 2010.
Jul 2010
13 Jul · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended June 30, 2010.
Apr 2010
22 Apr · Board meeting
To consider and to take on record the Audited Financial Results and declaration / recommendation of dividend for the year ended March 31, 2010.
Jan 2010
15 Jan · Board meeting
Meeting on 23 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
14 Oct · Board meeting
Meeting on 22 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Jul 2009
15 Jul · Board meeting
Meeting on 23 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
22 Jun · Board meeting
To consider and to take on record the Audited Financial Results for the year ended March 31, 2009.
Mar 2009
23 Mar · Board meeting
For considering a proposal for merger of Hikal Pharmaceuticals Limited, a wholly owned subsidiary of the Company, with itself pursuant to a Scheme of Arrangement and all matters related and incidental thereto.
Jan 2009
20 Jan · Board meeting
Board of Directors of the Company at their meeting held on January 20, 2009, has deferred the decision regarding declaration of Interim Dividend.12 Jan · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended December 31, 2008. In this meeting, the Board will also consider the declaration of Interim Dividend for the year 2008-2009.
Oct 2008
14 Oct · Board meeting
Meeting on 22 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Jul 2008
8 Jul · Board meeting
Meeting on 17 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Jun 2008
24 Jun · Board meeting
To consider and to take on record the Audited Financial Results and recommendation of final dividend for the year ended March 31, 2008.
Apr 2008
21 Apr · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended March 31, 2008.
Jan 2008
8 Jan · Board meeting
To consider and take on record the Unaudited Financial Results for the quarter ended December 31, 2007. Further, in this meeting, the Board will also consider the declaration of Interim Dividend for the year 2007-2008.